Journal
CURRENT OPINION IN HEMATOLOGY
Volume 21, Issue 4, Pages 309-319Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOH.0000000000000051
Keywords
chronic inflammation; MALT lymphoma; MALT1 paracaspase; NF-kappa B; TNFAIP3/A20
Categories
Funding
- Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness [FIS-PI12/00202, RTICC-RD12/0036/0063-FEDER]
Ask authors/readers for more resources
Purpose of review Extranodal mucosa-associated lymphoid tissue (MALT lymphoma) is a distinct clinical-pathological entity that can be distinguished from other lymphomas by a number of unique features, including their location in various extranodal sites, being preceded by chronic inflammatory or infection processes; a characteristic histopathological picture; and the presence of exclusive chromosomal translocations which increase MALT1 proteolytic activity to promote constitutive NF-kappa B signaling and eventually drive lymphomagenesis. Recent findings This review explores the major molecular and cellular events that participate in MALT lymphoma pathogenesis, focusing on gastric MALT lymphoma as a model of chronic inflammation-induced tumor development. In addition, the pivotal roles of activated MALT1 protease, its substrate TNFAIP3/A20, and the MyD88 adaptor protein in abnormally triggering downstream NF-kappa B pathway are overviewed. These new insights provide a mechanistic basis for using novel therapies targeting MALT1 protease or IRAK4 kinase activities. Finally, the putative cellular origin of MALT lymphomas is also discussed. Summary Over the last decade, unraveling the biological complexity of MALT lymphomas has shed light on the fundamental cellular and molecular aspects of the disease that are to be translated into clinical diagnostics and therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available